glp 1 compounding news FDA GLP-1 Alert: California Pharmacy Shut Down! DOWNSIZED semaglutide compounding news fda FDA

Additionally, the weight loss achieved with Mounjaro, whilst therapeutically beneficial, sometimes occurs rapidly

doi: 10.3389/fendo.2024.1391891 10 LiLYangYCaoYZhanJWuYWuC

Longer breaks (4+ weeks) typically trigger significant metabolic shifts and weight rebound

Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin in type 2 diabetes mellitus (LEAD-2 Met)

They enrolled adults aged 55 to 85 with mild cognitive impairment or mild dementia due to Alzheimers disease, confirmed by amyloid status, and tested once-daily oral semaglutide against placebo on top of standard care